Clearstead Advisors’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Clearstead Advisors’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,426	Closed	-$22.5K	–	1655
2023 Q4	$22.5K	Sell	1,426 -1,426	-50%	-$13.7K	﹤0.01%	921
2023 Q3	$22.1K	Buy	+2,852	New	+$23.6K	﹤0.01%	1006

Clearstead Advisors's ICVX Position: Q1 2024 in Review

Clearstead Advisors sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 1,426 shares — an estimated $22.5K sold.

Clearstead Advisors first reported a position in ICVX in Q3 2023 and held it in 2 quarters. The position peaked at $22.5K in Q4 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

Clearstead Advisors reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Clearstead Advisors sold 1,426 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $22.5K.
Clearstead Advisors first reported a position in Icosavax, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Clearstead Advisors's Icosavax, Inc. Common Stock position peaked at $22.5K in Q4 2023.
0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Clearstead Advisors's 13F filing for Q1 2024, filed 14 May 2024.